Search alternatives:
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
Showing 17,481 - 17,500 results of 104,446 for search '(( a step decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.65s Refine Results
  1. 17481
    Ginkgolide B decreases Nrf2 expression without reducing the level of Nrf2 mRNA in ox-LDL-stimulated endothelial cells.

    Ginkgolide B decreases Nrf2 expression without reducing the level of Nrf2 mRNA in ox-LDL-stimulated endothelial cells. by Lina Ma (199509)

    Published 2013
    Save to List
    Saved in:
  2. 17482
    Intramolecularly Coordinated (6-(Diphenylphosphino)acenaphth-5-yl)stannanes. Repulsion vs Attraction of P- and Sn-Containing Substituents in the <i>peri</i> Positions

    Intramolecularly Coordinated (6-(Diphenylphosphino)acenaphth-5-yl)stannanes. Repulsion vs Attraction of P- and Sn-Containing Substituents in the <i>peri</i> Positions by Emanuel Hupf (1489165)

    Published 2014
    “…With an increasing number of Cl atoms attached to the Sn atom, the Sn–P bond becomes considerably shorter and exhibits a decreasingly polar covalent interaction. As expected, this trend is significantly enhanced for the Sn–P interactions in the charged compounds <b>7a</b>,<b>b</b>. …”
    Save to List
    Saved in:
  3. 17483
    Figure S6 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes

    Figure S6 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes by Pauline J. van der Watt (15068109)

    Published 2023
    Save to List
    Saved in:
  4. 17484
    Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i>

    Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i> by Jannet A. Tobon Ramos (20855642)

    Published 2025
    “…Twelve months following MDA, the seroprevalence decreased in the IDA arm to 88 of 212 (41.5%) compared to 100 of 185 (54%) in the DA arm (<i>p</i> = 0.012, chi-square) (<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0012851#pntd.0012851.t004" target="_blank">Table 4A</a>). …”
    Save to List
    Saved in:
  5. 17485
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  6. 17486
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  7. 17487
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  8. 17488
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  9. 17489
    Figure S2 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes

    Figure S2 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes by Pauline J. van der Watt (15068109)

    Published 2023
    Save to List
    Saved in:
  10. 17490
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  11. 17491
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  12. 17492
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  13. 17493
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  14. 17494
    Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance

    Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance by Niklas Klümper (15048887)

    Published 2023
    Save to List
    Saved in:
  15. 17495
    Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance

    Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance by Niklas Klümper (15048887)

    Published 2023
    Save to List
    Saved in:
  16. 17496
    IGF1R was phosphorylated on hypoxic GRPs, and knockdown of IGF1 decreased the population of CD133- and Oct4-positive hypoxic GRPs.

    IGF1R was phosphorylated on hypoxic GRPs, and knockdown of IGF1 decreased the population of CD133- and Oct4-positive hypoxic GRPs. by Akiko Murakami (515972)

    Published 2014
    Save to List
    Saved in:
  17. 17497
    DURING THE CORONAVIRUS (COVID-19) PANDEMIC, DOES WEARING A MASK IMPROVE OR WORSEN PHYSICAL PERFORMANCE?

    DURING THE CORONAVIRUS (COVID-19) PANDEMIC, DOES WEARING A MASK IMPROVE OR WORSEN PHYSICAL PERFORMANCE? by Paulo Roberto Santos-Silva (2735518)

    Published 2021
    “…Secretory immunoglobulin A (IgA) is an antibody protein used by the immune system to neutralize pathogens, including viruses, and decreases with intense exercise. …”
    Save to List
    Saved in:
  18. 17498
    The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia

    The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia by Daniel Landau (440830)

    Published 2018
    “…Rats were sacrificed 4 weeks after CKD induction and 5 minutes after a single bolus of IV recombinant human EPO. …”
    Save to List
    Saved in:
  19. 17499
    Cation Control of Cooperative CO<sub>2</sub> Adsorption in Li-Containing Mixed Cation Forms of the Flexible Zeolite Merlinoite

    Cation Control of Cooperative CO<sub>2</sub> Adsorption in Li-Containing Mixed Cation Forms of the Flexible Zeolite Merlinoite by Veselina M. Georgieva (7125887)

    Published 2021
    “…The lithium-exchanged form of a merlinoite zeolite (MER) with Si/Al = 4.2 (unit cell composition Li<sub>6.2</sub>Al<sub>6.2</sub>Si<sub>25.8</sub>O<sub>64</sub>) possesses a strongly contracted framework when dehydrated (the unit cell volume decreases by 12.9% from the hydrated “wide-pore” form to the dehydrated “narrow-pore” form). …”
    Save to List
    Saved in:
  20. 17500
    Cation Control of Cooperative CO<sub>2</sub> Adsorption in Li-Containing Mixed Cation Forms of the Flexible Zeolite Merlinoite

    Cation Control of Cooperative CO<sub>2</sub> Adsorption in Li-Containing Mixed Cation Forms of the Flexible Zeolite Merlinoite by Veselina M. Georgieva (7125887)

    Published 2021
    “…The lithium-exchanged form of a merlinoite zeolite (MER) with Si/Al = 4.2 (unit cell composition Li<sub>6.2</sub>Al<sub>6.2</sub>Si<sub>25.8</sub>O<sub>64</sub>) possesses a strongly contracted framework when dehydrated (the unit cell volume decreases by 12.9% from the hydrated “wide-pore” form to the dehydrated “narrow-pore” form). …”
    Save to List
    Saved in:

Search Tools: